Clearance of prions during plasma protein manufacture

Transfusion Medicine Reviews

Volumn 20, Issue 1, 2006, Pages 57-62

  Burdick, Michael D ^a   Pifat, Dominique Y ^a   Petteway Jr , Stephen R ^a   Cai, Kang ^a  

^a Talecris Biotherapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; PRION PROTEIN;

BRAIN DISEASE; DISEASE ASSOCIATION; HUMAN; NONHUMAN; PHYSICAL CHEMISTRY; PURIFICATION; REVIEW; SAFETY; VIRUS INACTIVATION;

EID: 29144486095     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2005.08.005     Document Type: Article

References (28)

1. P. Brown, R.G. Rohwer, and B.C. Dunstan The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy Transfusion 38 1998 810 816
2. P. Brown, L. Cervenakova, and L.M. McShane Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans Transfusion 39 1999 1169 1178
3. F. Houston, J.D. Foster, and A. Chong Transmission of BSE by blood transfusion in sheep Lancet 356 2000 999 1000
4. N. Hunter, J. Foster, and A. Chong Transmission of prion diseases by blood transfusion J. Gen. Virol. 83 2002 2897 2905
5. C.A. Llewelyn, P.E. Hewitt, and R.S. Knight Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion Lancet 363 2004 417 421
6. A.H. Peden, M.W. Head, and D.L. Ritchie Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient Lancet 364 2004 527 529
7. T. Burnouf, and M. Radosevich Reducing the risk of infection from plasma products: Specific preventative strategies Blood Rev. 14 2000 94 110
8. S.B. Prusiner, M.P. McKinley, and D.F. Groth Scrapie agent contains a hydrophobic protein Proc. Natl. Acad. Sci. U. S. A. 78 1981 6675 6679
9. S.B. Prusiner, M.P. McKinley, and K.A. Bowman Scrapie prions aggregate to form amyloid-like birefringent rods Cell 35 1983 349 358
10. K. Cai, J.L. Miller, and C.J. Stenland Solvent-dependent precipitation of prion protein Biochim. Biophys. Acta 1597 2002 28 35
11. C.J. Stenland, D.C. Lee, and P. Brown Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma Transfusion 42 2002 1497 1500
12. P.R. Foster, A.G. Welch, and C. McLean Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products Vox Sang. 78 2000 86 95
13. R.W. Van Holten, S. Autenrieth, and J.A. Boose Removal of prion challenge from an immune globulin preparation by use of a size-exclusion filter Transfusion 42 2002 999 1004
14. D.C. Lee, C.J. Stenland, and J.L. Miller A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins Transfusion 41 2001 449 455
15. R.W. Van Holten, and S.M. Autenrieth Evaluation of depth filtration to remove prion challenge from an immune globulin preparation Vox Sang. 85 2003 20 24
16. P.R. Foster, C. McLean, and A.G. Welch Removal of abnormal prion protein by plasma fractionation Transfus. Sci. 22 2000 53 56
17. L. Gregori, J.A. Maring, and C. MacAuley Partitioning of TSE infectivity during ethanol fractionation of human plasma Biologicals 32 2004 1 10
18. M. Ceroni, P. Piccardo, and J. Safar Scrapie infectivity and prion protein are distributed in the same pH range in agarose isoelectric focusing Neurology 40 1990 508 513
19. M. Vey, H. Baron, and T. Weimer Purity of spiking agent affects partitioning of prions in plasma protein purification Biologicals 30 2002 187
20. D.C. Lee, C.J. Stenland, and R.C. Hartwell Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein J. Virol. Methods 84 2000 77 89
21. J. Safar, H. Wille, and V. Itri Eight prion strains have PrP(Sc) molecules with different conformations Nat. Med. 4 1998 1157 1165
22. A. Bellon, W. Seyfert-Brandt, and W. Lang Improved conformation-dependent immunoassay: Suitability for human prion detection with enhanced sensitivity J. Gen. Virol. 84 2003 1921 1925
23. J.G. Safar, M.D. Geschwind, and C. Deering Diagnosis of human prion disease Proc. Natl. Acad. Sci. U. S. A. 102 2005 3501 3506
24. R.C. Hartwell, M.S. Nelson, and M.M. Kislan An improved Western blot assay to assess the clearance of prion protein from plasma-derived therapeutic proteins J. Virol. Methods 125 2005 187 193
25. A.H. McLeod, H. Murdoch, and J. Dickinson Proteolytic inactivation of the bovine spongiform encephalopathy agent Biochem. Biophys. Res. Commun. 317 2004 1165 1170
26. P.J. Bosque, and S.B. Prusiner Cultured cell sublines highly susceptible to prion infection J. Virol. 74 2000 4377 4386
27. S. Cronier, H. Laude, and J.M. Peyrin Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death Proc. Natl. Acad. Sci. U. S. A. 101 2004 12271 12276
28. P.C. Klohn, L. Stoltze, and E. Flechsig A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions Proc. Natl. Acad. Sci. U. S. A. 100 2003 11666 11671